News Releases

January 16, 2019

Newly published research has identified how the immune system senses nanomedicines and triggers their elimination

In a newly published collaborative study in Nature Nanotechnology (https://www.nature.com/articles/s41565-018-0344-3), between Professor Moein Moghimi at Newcastle University, U.K., and a founding member of SMDG, a life sciences and biotechnology company, and researchers at the University of Colorado, the mechanism by which the human immune system recognizes and rejects nanoparticles has been deciphered to help researchers find more effective ways to deliver nanomedicines.

https://www.nature.com/articles/s41565-018-0344-3

SMDG Receives U.S. Patent For Innovative Nano-delivery System

SMDG announces that it was granted a primary patent in May by the U.S. Patent and Trademark Office (USPTO) for its proprietary nano-delivery system.

September 24, 2018

Geoff Lewis named SMDG’s Senior VP, Legal Counsel

SMDG announces the addition of Geoff Lewis as its Senior Vice President, Legal Counsel. Lewis brings over a billion dollars of transactional experience in securities, IPOs, mergers & acquisitions, corporate finance, joint ventures and contracts with one of the largest corporate law firms in the world and three NYSE-listed companies.

June 28, 2018

Two World-renowned Neuroscientists Join SMDG's Distinguished Advisory Board

SM Discovery Group (SMDG), a life sciences and bio-nanotechnology company that has developed a ground-breaking nano-delivery system for unimpeded penetration of physiological barriers, announced the addition of Drs. Marc A. Dichter, M.D., Ph.D., and Dennis W. Choi, M.D., Ph.D. to its advisory board.

May 01, 2018

Gary A. Leo joins SMDG as Senior VP of Corporate Development

SMDG announced the addition of Gary A. Leo as its Senior Vice President of Corporate Development.

February 02, 2018

SMDG selects the internationally renowned legal firm of Cooley LLP as its primary outside counsel

SMDG announces the addition of Cooley LLP as its primary outside counsel.

November 30, 2017

Dr. A. Waseem Malick, industry-recognized drug-delivery expert, joins SM Discovery Group’s Advisory Board

SM Discovery Group (SMDG), announces the addition of Dr. A. Waseem Malick to its advisory board.

Geometry and particle hitch-hiking: A new window—and possible breakthrough—into improving nanopharmaceuticals for personalized medicine

Geometry and hitch-hiking are not the first things that come to mind regarding the immune system. However, the recent work by Moein Moghimi, Professor and Chair of pharmaceutics at Durham University, UK and collaborators shows that geometry is key in nanoparticle recognition by the immune system.

Please reload